i2o Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- i2o Therapeutics's estimated annual revenue is currently $1.3M per year.
- i2o Therapeutics's estimated revenue per employee is $77,500
- i2o Therapeutics's total funding is $54M.
Employee Data
- i2o Therapeutics has 17 Employees.
- i2o Therapeutics grew their employee count by -6% last year.
i2o Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Chairman, President & CEO | Reveal Email/Phone |
2 | Chairman, President and CEO | Reveal Email/Phone |
3 | VP, Research and Program Management | Reveal Email/Phone |
4 | Senior Director Technology Development | Reveal Email/Phone |
5 | Animal/ Laboratory Technician | Reveal Email/Phone |
6 | Research Associate | Reveal Email/Phone |
7 | Research Scientist | Reveal Email/Phone |
8 | Research Associate | Reveal Email/Phone |
9 | Research Scientist | Reveal Email/Phone |
10 | Research Scientist | Reveal Email/Phone |
i2o Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is i2o Therapeutics?
i2o Therapeutics is a biotech company developing safe and effective oral formulations of therapies traditionally limited to injections.
keywords:N/A$54M
Total Funding
17
Number of Employees
$1.3M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.3M | 17 | -78% | $274M |
#2 | $1.5M | 17 | -15% | N/A |
#3 | $2.1M | 17 | 0% | N/A |
#4 | $2.4M | 17 | 42% | N/A |
#5 | $1.4M | 17 | 0% | N/A |